Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Capital Employed (2021 - 2026)

Journey Medical filings provide 5 years of Return on Capital Employed readings, the most recent being 4.55% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 3244.0% to 4.55% in Q4 2025 year-over-year; TTM through Dec 2025 was 4.55%, a 3244.0% increase, with the full-year FY2025 number at 4.78%, up 2676.0% from a year prior.
  • Return on Capital Employed hit 4.55% in Q4 2025 for Journey Medical, up from 12.64% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 6.69% in Q2 2024 to a low of 251.26% in Q2 2023.
  • Median Return on Capital Employed over the past 5 years was 51.57% (2023), compared with a mean of 55.43%.
  • Biggest five-year swings in Return on Capital Employed: tumbled -19918bps in 2023 and later soared 25795bps in 2024.
  • Journey Medical's Return on Capital Employed stood at 83.93% in 2021, then grew by 18bps to 69.1% in 2022, then skyrocketed by 90bps to 7.02% in 2023, then crashed by -427bps to 37.0% in 2024, then soared by 88bps to 4.55% in 2025.
  • The last three reported values for Return on Capital Employed were 4.55% (Q4 2025), 12.64% (Q3 2025), and 16.11% (Q2 2025) per Business Quant data.